Literature DB >> 8675301

Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii.

E Grunvald1, M Chiaramonte, S Hieny, M Wysocka, G Trinchieri, S N Vogel, R T Gazzinelli, A Sher.   

Abstract

Previous reports have indicated that the early induction of interleukin-12 (IL-12), tumor necrosis factor alpha (TNF-alpha), IL-1beta, and IL-10 is crucial for the establishment and regulation of host cell-mediated immunity to the intracellular protozoan parasite Toxoplasma gondii. In this study, we demonstrate that a soluble tachyzoite extract (soluble tachyzoite antigen) can trigger the expression of these four monokines by murine inflammatory macrophages. Further characterization revealed that the parasite molecules in soluble tachyzoite antigen responsible for monokine induction are heat stable at 100 degree C but differ in sensitivity to protease digestion. Thus, the tachyzoite factors that stimulate TNF-alpha and IL-to expression were found to be more resistant to treatment with proteinase K than those responsible for IL-12 and IL-10 induction. Similarly, while the factors responsible for the induction of all four monokines were found to be sensitive to periodate oxidation, the TNF-alpha-stimulating activity was partially resistant to treatment with the compound at a low concentration (1 mM). A further dichotomy in monokine induction signals was inferred from experiments with isoquinoline sulfonamide protein kinase inhibitors. The latter work suggested that the pathways for TNF-alpha and IL-1beta are protein kinase C dependent, while expression of IL-12 and expression of IL-10 share distinct signal transduction mechanisms involving other kinases. Together, these data argue that monokine induction by T. gondii is mediated by glycoproteins that may belong to distinct groups in terms of their biochemical properties and intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675301      PMCID: PMC174030          DOI: 10.1128/iai.64.6.2010-2018.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Toxins, cytokines, immunity and pathology.

Authors:  J H Playfair
Journal:  Immunol Lett       Date:  1991-10       Impact factor: 3.685

2.  Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.

Authors:  A Sher; I P Oswald; S Hieny; R T Gazzinelli
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

3.  A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

5.  Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages.

Authors:  C L Manthey; M E Brandes; P Y Perera; S N Vogel
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

6.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

7.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

8.  Macrophage activation during Plasmodium chabaudi AS infection in resistant C57BL/6 and susceptible A/J mice.

Authors:  M M Stevenson; D Y Huang; J E Podoba; M E Nowotarski
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.

Authors:  L Carrera; R T Gazzinelli; R Badolato; S Hieny; W Muller; R Kuhn; D L Sacks
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Authors:  A D'Andrea; M Rengaraju; N M Valiante; J Chehimi; M Kubin; M Aste; S H Chan; M Kobayashi; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  32 in total

1.  Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP.

Authors:  G A Taylor; C M Collazo; G S Yap; K Nguyen; T A Gregorio; L S Taylor; B Eagleson; L Secrest; E A Southon; S W Reid; L Tessarollo; M Bray; D W McVicar; K L Komschlies; H A Young; C A Biron; A Sher; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor.

Authors:  Eric D Phelps; Kristin R Sweeney; Ira J Blader
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

3.  NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection.

Authors:  Romina S Goldszmid; Pat Caspar; Aymeric Rivollier; Sandy White; Amiran Dzutsev; Sara Hieny; Brian Kelsall; Giorgio Trinchieri; Alan Sher
Journal:  Immunity       Date:  2012-06-29       Impact factor: 31.745

4.  Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages.

Authors:  C A Salkowski; G R Detore; S N Vogel
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice.

Authors:  Elizabeth A Wohlfert; John R Grainger; Nicolas Bouladoux; Joanne E Konkel; Guillaume Oldenhove; Carolina Hager Ribeiro; Jason A Hall; Ryoji Yagi; Shruti Naik; Ravikiran Bhairavabhotla; William E Paul; Remy Bosselut; Gang Wei; Keji Zhao; Mohamed Oukka; Jinfang Zhu; Yasmine Belkaid
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

6.  Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase.

Authors:  Ningfeng Tang; Liming Liu; Kefei Kang; Pranab K Mukherjee; Masakazu Takahara; Guofen Chen; Thomas S McCormick; Kevin D Cooper; Mahmoud Ghannoum
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Elevating calcium in Th2 cells activates multiple pathways to induce IL-4 transcription and mRNA stabilization.

Authors:  Liying Guo; Joseph F Urban; Jinfang Zhu; William E Paul
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  The IL-12 Response of Primary Human Dendritic Cells and Monocytes to Toxoplasma gondii Is Stimulated by Phagocytosis of Live Parasites Rather Than Host Cell Invasion.

Authors:  Kevin W Tosh; Lara Mittereder; Sandra Bonne-Annee; Sara Hieny; Thomas B Nutman; Steven M Singer; Alan Sher; Dragana Jankovic
Journal:  J Immunol       Date:  2015-11-23       Impact factor: 5.422

9.  In situ IL-12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli.

Authors:  Antonio Gigliotti Rothfuchs; Jackson G Egen; Carl G Feng; Lis R V Antonelli; Andre Bafica; Nathalie Winter; Richard M Locksley; Alan Sher
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

10.  Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells.

Authors:  Romina S Goldszmid; Isabelle Coppens; Avital Lev; Pat Caspar; Ira Mellman; Alan Sher
Journal:  J Exp Med       Date:  2009-01-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.